Larvol Delta - Marker-Therapeuticsannounced-that-data-from-the-Phase-1-APOLLO-study-will-be-presented-in-two-posters-at-the-67th-American-Society-of-Hematology-ASH-Annual-Meeting

neldaleucel (MT-601) - Marker Therap

https://www.globenewswire.com/news-release/2025/11/03/3179422/0/en/Marker-Therapeutics-Announces-Upcoming-Presentations-on-MT-601-in-Relapsed-Non-Hodgkin-and-Hodgkin-Lymphoma-at-the-67th-ASH-Annual-Meeting.html

Nov 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next